메뉴 건너뛰기




Volumn 96, Issue 2, 2002, Pages 197-199

Is the exclusion of children under 24 months from anthelmintic treatment justifiable?

Author keywords

Adverse effects; Age; Anthelmintics; Children; Children under 2 years; Clinical trial; Mebendazole; Safety; Tanzania

Indexed keywords

ANTHELMINTIC AGENT; BENZIMIDAZOLE DERIVATIVE; MEBENDAZOLE; PLACEBO;

EID: 0036323056     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(02)90303-2     Document Type: Article
Times cited : (48)

References (11)
  • 11
    • 0003473848 scopus 로고    scopus 로고
    • Report of the WHO informal consultation on the use of chemotherapy for the control of morbidity due to soil-transmitted nematodes in humans
    • WHO Geneva: World Health Organization. WHO/CTD/SIP/96.2.
    • (1996)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.